Application and Influence of Dapagliflozin in Patients with Type 2 Diabetes Mellitus

Abstract

The morbidity of diabetes is gradually increasing, among which type 2 diabetes accounts for about 90%. Type 2 diabetes is a chronic disease with complex pathogenesis, mainly characterized by insulin deficiency or insulin resistance, and its complications seriously affect people’s quality of life and threaten people’s life and health. Dapagliflozin, as a sodium-glucose cotransporter 2 inhibitor, does not depend on insulin. In addition to control the blood glucose level, dapagliflozin can also reduce body weight, blood pressure and improve blood lipids. More importantly, in recent years, people have found that it also plays an important role in the protection of heart and kidney. This article mainly describes the main application and influence of dapagliflozin in patients with type 2 diabetes mellitus, in order to provide reference for clinical medication.